Landeshauptstadt Dresden - www.dresden.de

https://www.dresden.de/en/business/location/key-sectors/biotech/research.php 17.10.2016 12:18:03 Uhr 21.10.2017 23:29:00 Uhr

Business Location Dresden

Life Sciences / Biotechnology: Research

Dresden has a network in biomedical research that has gained global attention. Focus areas of are

  • Molecular Bioengineering,
  • Regenerative Therapies,
  • Tissue Engeneering,
  • Stem Cell Research and
  • Systems Biology.

Its core is the DFG Research Center for Regenerative Therapies Dresden which was established in 2006. It is the first research center of the German Research Foundation (DFG) in the new federal states and, at the same time, the first center with a focus on adult stem cells.

This research center was expanded through the establishment of the Cluster of Excellence »From Cells to Tissues to Therapies« at Technische Universität Dresden (TU Dresden) which is the only East German cluster of excellence to be supported by the Federal Government within the scope of its Initiative of Excellence.

Together with the Dresden International Graduate School for Biomedicine and Bioengineering (DIGS-BB) two essential features of Dresden University of Technology (a University of Excellence) fall under the key sector of the life sciences / biotechnology.

Current projects make progress with the next stages of development. Dresden's research landscape has been extended during the past few years with the Center of Innovative Competence B-Cube (B³) and part of the German Center of neurodegenerative diseases.

In 2012 the Max Planck Society founded a new research center in Dresden, the Center for Systems Biology. The director is Gene Myers, a trailblazer in bioinformatics.

Today international researchers from the fields of medicine, cell biology, genetics, developmental biology, biophysics, and engineering sciences all work together so that the combination of the insights gleaned from fundamental research and combined with technological knowledge may be applied efficiently and effectively in stem cell therapies in patients.

This network is primarily supported by, for example:

Print

Partner